SBC Medical Group Holdings (SBC) Stock Statistics & Valuation Metrics

SBC Medical Group Holdings has a market cap or net worth of $518.35M. The enterprise value is $195.63M.

Market Cap

$518.35M

Enterprise Value

$195.63M

SBC Medical Group Holdings has 102,846,950 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

102,846,950

Owned by Insiders

82.36%

Owned by Institutions

4.82%

SBC Medical Group Holdings’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 12.61%.

Return on Equity (ROE)

0.21

Return on Assets (ROA)

0.13

Return on Invested Capital (ROIC)

12.61%

Return on Capital Employed (ROCE)

0.21

Revenue Per Employee

201.17K

Profits Per Employee

59.08K

Employee Count

863

Asset Turnover

0.46

Inventory Turnover

16.59

The current PE Ratio of SBC Medical Group Holdings is 10.72. SBC Medical Group Holdings’s PEG ratio is 0.25.

PE Ratio

10.72

PS Ratio

2.96

PB Ratio

1.96

Price to FCF

6.92

Price to Operating Cash Flow

6.71

PEG Ratio

0.25

In the last 12 months, SBC Medical Group Holdings had revenue of 173.61M and earned 50.99M in profits. Earnings per share was 0.50.

Revenue

173.61M

Gross Profit

127.28M

Operating Income

67.49M

Pretax Income

82.07M

Net Income

50.99M

EBITDA

84.91M

Earnings Per Share (EPS)

0.50

In the last 12 months, operating cash flow was 77.07M and capital expenditures -2.12M, giving a free cash flow of 74.96M billion.

Operating Cash Flow

77.07M

Free Cash Flow

74.96M

Free Cash Flow per Share

0.73

SBC Medical Group Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

14.46%

Earnings Yield

9.48%

Beta

0.45

52-Week Price Change

63.64%

50-Day Moving Average

4.95

200-Day Moving Average

3.92

Relative Strength Index (RSI)

45.99

Average Volume (3m)

199.86K

SBC Medical Group Holdings upcoming earnings date is Nov 13, 2026, Before Open (Not Confirmed).

Last Earnings Date

Aug 13, 2026

Next Earnings Date

Nov 13, 2026

Ex-Dividend Date

―

SBC Medical Group Holdings as a current ratio of 3.78, with Debt / Equity ratio of 20.80%

Current Ratio

3.78

Quick Ratio

3.74

Debt to Market Cap

0.10

Net Debt to EBITDA

-1.32

Interest Coverage Ratio

420.26

In the past 12 months, SBC Medical Group Holdings has paid 31.02M in taxes.

Income Tax

31.02M

Effective Tax Rate

0.38

SBC Medical Group Holdings EV to EBITDA ratio is 4.92, with an EV/FCF ratio of 5.10.

EV to Sales

2.18

EV to EBITDA

4.92

EV to Free Cash Flow

5.10

EV to Operating Cash Flow

4.96

SBC Medical Group Holdings has $184.62M in cash and marketable securities with $48.23M in debt, giving a net cash position of $136.39M billion.

Cash & Marketable Securities

$184.62M

Total Debt

$48.23M

Net Cash

$136.39M

Net Cash Per Share

$1.33

Tangible Book Value Per Share

$2.14

Gross margin is 71.27%, with operating margin of 37.34%, and net profit margin of 27.99%.

Gross Margin

71.27%

Operating Margin

37.34%

Pretax Margin

43.09%

Net Profit Margin

27.99%

EBITDA Margin

44.31%

EBIT Margin

42.47%

The average price target for SBC Medical Group Holdings is $8.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

$8.50

Price Target Upside

68.65% Upside

Analyst Consensus

Moderate Buy

Analyst Count

2

Revenue Growth Forecast

-6.92%

EPS Growth Forecast

46.87%

Smart Score

7

AI Score

80